SAN FRANCISCO – A host of biotech execs and investors converge at the Palace Hotel here Tuesday for the two-day BIO Investor Forum, hoping to spark renewed vigor in a sector that's just come off a bleak third quarter in terms of fundraising, with public and private financings for the industry down 48 percent compared to last year.